Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
Nu Skin Enterprises (NYSE: NUS) has announced that its Q4 2024 preliminary revenue is at the high end of the company's guidance range. This announcement comes ahead of its presentation at the ICR Conference on Jan. 14, where President and CEO Ryan Napierski, along with CFO James Thomas, will discuss the company's strategy and performance, including the recent strategic acquisition of Mavely for $250 million. The presentation will be webcast live at 3 p.m. ET on the company's investor relations page, with an archive available through Jan. 28.
Nu Skin will release its full Q4 and full year 2024 financial results after market close on Feb. 13. Following the release, the management team will host a conference call at 5 p.m. ET, which will also be webcast live on the investor relations page. A replay will be accessible through Feb. 27.
Nu Skin Enterprises (NYSE: NUS) ha annunciato che il suo fatturato preliminare del Q4 2024 si colloca nella fascia alta delle previsioni aziendali. Questo annuncio arriva prima della sua presentazione alla ICR Conference il 14 gennaio, dove il Presidente e CEO Ryan Napierski, insieme al CFO James Thomas, discuteranno della strategia e delle performance dell'azienda, inclusa la recente acquisizione strategica di Mavely per 250 milioni di dollari. La presentazione sarà trasmessa in diretta sul sito delle relazioni con gli investitori dell'azienda, con un archivio disponibile fino al 28 gennaio.
Nu Skin pubblicherà i suoi risultati finanziari completi del Q4 e dell'intero anno 2024 dopo la chiusura del mercato il 13 febbraio. Dopo la pubblicazione, il team dirigenziale ospiterà una conference call alle 17:00 ET, che sarà anch'essa trasmessa in diretta sulla pagina delle relazioni con gli investitori. Una registrazione sarà accessibile fino al 27 febbraio.
Nu Skin Enterprises (NYSE: NUS) ha anunciado que su ingreso preliminar del Q4 2024 se encuentra en el extremo superior de la guía de la compañía. Este anuncio llega antes de su presentación en la ICR Conference el 14 de enero, donde el Presidente y CEO Ryan Napierski, junto con el CFO James Thomas, discutirán la estrategia y desempeño de la empresa, incluida la reciente adquisición estratégica de Mavely por 250 millones de dólares. La presentación se transmitirá en vivo en la página de relaciones con los inversores de la compañía, con un archivo disponible hasta el 28 de enero.
Nu Skin publicará sus resultados financieros completos del Q4 y del año completo 2024 después del cierre del mercado el 13 de febrero. Tras la publicación, el equipo directivo llevará a cabo una conferencia telefónica a las 17:00 ET, que también se transmitirá en vivo en la página de relaciones con los inversores. La grabación estará disponible hasta el 27 de febrero.
Nu Skin Enterprises (NYSE: NUS)는 2024년 4분기 예상 수익이 회사의 가이던스 범위 상단에 위치하고 있다고 발표했습니다. 이 발표는 1월 14일 ICR 컨퍼런스에서의 발표를 앞두고 이루어졌으며, 그 동안 대통령 겸 CEO인 Ryan Napierski와 CFO James Thomas는 Mavely를 2억 5천만 달러에 인수한 최근의 전략적 성과와 함께 회사의 전략 및 성과에 대해 논의할 것입니다. 발표는 회사의 투자자 관계 페이지에서 오후 3시에 생중계될 예정이며, 1월 28일까지 아카이브가 가능합니다.
Nu Skin은 2월 13일 마감 이후에 2024년 4분기 및 연간 재무 결과를 발표할 것입니다. 발표 후 경영진 팀은 오후 5시에 전화 회의를 개최할 것이며, 이 또한 투자자 관계 페이지에서 생중계될 예정입니다. 녹화본은 2월 27일까지 접근할 수 있습니다.
Nu Skin Enterprises (NYSE: NUS) a annoncé que son chiffre d'affaires préliminaire pour le Q4 2024 est à la limite supérieure de la fourchette de prévisions de l'entreprise. Cette annonce intervient avant sa présentation à la ICR Conference le 14 janvier, où le Président et CEO Ryan Napierski, accompagné du CFO James Thomas, discutera de la stratégie et de la performance de l'entreprise, y compris l'acquisition stratégique récente de Mavely pour 250 millions de dollars. La présentation sera diffusée en direct à 15 h, heure de l'Est, sur la page des relations avec les investisseurs de l'entreprise, avec un archive disponible jusqu'au 28 janvier.
Nu Skin publiera ses résultats financiers complets du Q4 et de l'année 2024 après la fermeture du marché le 13 février. Suite à cette publication, l'équipe de direction tiendra une conférence téléphonique à 17 h, heure de l'Est, qui sera également diffusée en direct sur la page des relations avec les investisseurs. Une rediffusion sera accessible jusqu'au 27 février.
Nu Skin Enterprises (NYSE: NUS) hat angekündigt, dass der vorläufige Umsatz für Q4 2024 am oberen Ende des Unternehmensleitfadens liegt. Diese Ankündigung erfolgt vor der Präsentation auf der ICR-Konferenz am 14. Januar, bei der Präsident und CEO Ryan Napierski sowie CFO James Thomas die Strategie und Leistung des Unternehmens besprechen werden, einschließlich der kürzlichen strategischen Übernahme von Mavely für 250 Millionen US-Dollar. Die Präsentation wird um 15:00 Uhr ET live auf der Investor-Relations-Seite des Unternehmens übertragen, mit einem Archiv, das bis zum 28. Januar verfügbar ist.
Nu Skin wird seine vollständigen Q4- und Jahresfinanzergebnisse 2024 nach Marktschluss am 13. Februar veröffentlichen. Nach der Veröffentlichung wird das Managementteam um 17:00 Uhr ET eine Telefonkonferenz abhalten, die ebenfalls live auf der Investor-Relations-Seite übertragen wird. Eine Aufzeichnung wird bis zum 27. Februar verfügbar sein.
- Q4 2024 preliminary revenue is at the high end of guidance.
- Strategic acquisition of Mavely for $250 million.
- None.
Insights
Company to discuss performance, strategy and opportunities at ICR Conference; full financial results to be announced Feb. 13
The company's presentation will be webcast live beginning at 3 p.m. ET. Those wishing to access the event can visit the Nu Skin investor relations page at ir.nuskin.com. The archive of the webcast will be available at this same location through Tuesday, Jan. 28.
The company will release fourth quarter and full year 2024 results after the market closes on Thursday, Feb. 13. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. The webcast of the conference call, including the financial information presented, will be available on the company’s investor relations page at ir.nuskin.com. A replay of the webcast will be available at the same location through Thursday, Feb. 27.
About Nu Skin Enterprises Inc.
The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include statements of management's expectations regarding the company's fourth-quarter revenue. The forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to differ materially from the forward-looking statements expressed herein, including completion of the Company's closing and audit procedures, which may necessitate material adjustments to the preliminary revenue estimate, and other risks and uncertainties that are set forth in the documents the Company has filed with the Securities and Exchange Commission. The forward-looking statements set forth the Company's beliefs as of the date that such information was first provided, and the Company assumes no duty to update the forward-looking statements contained in this report to reflect any change except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113921582/en/
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577
Source: Nu Skin Enterprises Inc.
FAQ
What is the preliminary revenue for Nu Skin (NUS) in Q4 2024?
When will Nu Skin (NUS) release its Q4 and full year 2024 financial results?
What significant transaction did Nu Skin (NUS) recently complete?
When and where can I watch the Nu Skin (NUS) presentation at the ICR Conference?
How long will the replay of the Nu Skin (NUS) ICR Conference presentation be available?